Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Re-EValuating the Inhibition of Stress Erosions: Prophylaxis Against Gastrointestinal Bleeding in the Critically Ill (The REVISE) Trial

NCT03374800 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT03374800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03374800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Re-EValuating the Inhibition of Stress Erosions: Prophylaxis Against Gastrointestinal Bleeding in the Critically Ill (The REVISE) Trial
Lead sponsor
McMaster University
Phase
Phase 3
Overall status
Completed
Start date
July 9, 2018
Completion date
January 31, 2024
Enrollment
4,800 (actual)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal hemorrhage (clinically important, upper)